Cardiac Dimensions, a Kirkland, Wash., company with a technology to treat heart valve malfunction, has raised $53 million ...

A device in clinical development appears to be far safer and more effective than the TAVI devices currently being used ...

HighLife announced that it received FDA breakthrough device designation for its trans-septal mitral valve replacement (TMVR) ...

ST. LOUIS — Dr. Scally, a cardiothoracic surgeon with Prairie Cardiovascular in O’Fallon, Illinois, explains mitral valve ...

Patients who underwent transcatheter aortic valve replacement (TAVR) with a valve designed to treat aortic regurgitation had ...

Dear K.T.: Dexfenfluramine, aka Redux (also called "fen-phen" in combination with phentermine), was sold in the 1990s until ...

Patients who underwent transcatheter aortic valve replacement (TAVR) with a valve designed to treat aortic regurgitation had an overall mortality rate of just 8.1% at one year, well below the ...

JenaValve today announced new results from an expanded cohort receiving its Trilogy transcatheter heart valve (THV) system.

The chordae tendineae (CT), often referred to as the “heart strings,” are thin, tendinous structures that connect the heart valves to the papillary muscles, ensuring proper valve function. When these ...

Cardiac Dimensions has about 70 employees globally: 40 in Kirkland, 10 throughout the United States, and 20 in Europe.

Objective In this study, the impact of regular training on left ventricle morphology in a group of athletes with bicuspid aortic valve (BAV) was evaluated. Design Longitudinal cohort study. A group of ...